Medicine Shops Across India Face Shutdown as Chemists Protest E-Pharmacies
A nationwide strike by chemists and pharmacy owners is set to impact medicine availability across several parts of India, as thousands of medical stores protest against the growing influence of online pharmacies and instant medicine delivery platforms.
The protest, called by the All India Organisation of Chemists and Druggists (AIOCD), has brought the spotlight back on the ongoing battle between traditional pharmacy owners and e-pharmacy companies. The association claims that online medicine platforms are operating in a “legal grey area” without strict regulations, affecting both small businesses and patient safety.
According to the chemists’ body, many e-pharmacy platforms allegedly deliver medicines without proper prescription verification, while also offering massive discounts that local pharmacy owners simply cannot compete with. They argue that such practices are hurting lakhs of small medical shop owners across the country.
At the center of the controversy are two government notifications — GSR 220(E) and GSR 817(E). Pharmacy associations say these rules, introduced during and after the Covid-19 period, allowed online medicine delivery services to expand without a fully developed regulatory framework. The protestors are demanding that the government withdraw these notifications and create stricter laws for online medicine sales.
However, health authorities are trying to prevent panic among the public. The Central Drugs Standard Control Organisation (CDSCO) has directed states to ensure there is no shortage of essential medicines during the strike. In many cities, hospital-attached pharmacies and 24-hour medical stores are expected to remain open to avoid inconvenience for patients.
Interestingly, not all pharmacy associations are supporting the shutdown. Some state-level groups have reportedly decided to stay away after receiving assurances from drug regulators that their concerns are under review. This means the impact of the strike may vary from state to state.
While the protest is officially about regulations and business fairness, it also reflects a larger shift happening in India’s healthcare sector — where convenience-driven digital services are rapidly changing how people buy medicines. The coming days could prove crucial in deciding how India balances technology, business competition, and patient safety in the pharmaceutical industry.
